Key Trends Shaping the Future Automated Compounding Devices Market From 2025-2034: Innovations In IV Robotic Technology For Hospital Pharmacies

What Is the Estimated Market Size and Growth Rate for the Automated Compounding Devices Market?
The market size for automated compounding devices has seen robust growth in recent times. The market, which valued at $2.36 billion in 2024, is predicted to touch $2.53 billion in 2025, with a compound annual growth rate (CAGR) of 7.4%. Causes for growth in the preceding period include a rising number of chronic illness cases, an aging population, expansion in healthcare infrastructure, regulatory necessities, and a surge in medication blunders.

Expectations are high for significant expansion in the automated compounding devices market within the coming years, with projections showing it will reach a value of $3.34 billion by 2029, growing at a Compound Annual Growth Rate (CAGR) of 7.2%. The anticipated growth within this period can be linked to factors such as an increase in cancer cases, the broadening of global health services, heightened emphasis on patient safety, support from regulatory bodies, and a growing drive towards sustainability. Key trends expected to shape the market within the forecast period include advancements in telemedicine, remote healthcare, artificial intelligence, health sector digitalization, and real-time monitoring.

What Is Driving the Growth Trajectory of the Automated Compounding Devices Market?
The surge in personalized medicines is anticipated to boost the expansion of the automated compounding devices market. Personalized medicine, which customizes healthcare decisions, practices, interventions, and treatments to match the unique attributes of each patient, is becoming more prevalent thanks to advancements in genetic understanding, patient-specific data, and regulatory backing. Automated compounding devices (ACDs) are instrumental in personalized medicine as they facilitate the precise and accurate creation of customized medication formulations designed for particular patient requirements. These devices automate the combination of varying pharmaceutical ingredients in precise proportions, a critical element in the production of personalized treatments. For example, in February 2024, the FDA approved 16 new personalized therapies for patients with rare diseases for the year 2023, as reported by the Personalized Medicine Coalition, a non-profit organization based in the US. This was a significant increase from the six approvals in 2022. Consequently, the escalating number of personalized medicines is propelling the expansion of the automated compounding devices market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18231&type=smp

Who Are the Dominant Companies Influencing Automated Compounding Devices Market Trends?
Major companies operating in the automated compounding devices market are McKesson Corporation, Amerisource Bergen Corporation, Medtronic PLC, Becton Dickinson and Company, Baxter International Inc, B. Braun Melsungen AG, Fresenius Kabi AG, Grifols International S.A., Terumo Corporation, ICU Medical Inc., Omnicell Inc., Tecan Group Ltd., Cantel Medical Corp., Fagron N.V., Swisslog Healthcare, ScriptPro LLC, PharMEDium Services LLC, Loccioni Group S.p.A., ARxIUM Inc., Codonics Inc., Apexus Inc., Equashield LLC, Yuyama Mfg Co. Ltd., Shanghai Weibond Technology Co. Ltd., Quirem Medical B.V

How Is the Automated Compounding Devices Market Evolving?
Key players in the automated compounding device market are prioritizing the enhancement of patient safety and the reduction of medication errors through advanced technologies like robotic compounding. This approach is aimed at winning customer trust, meeting regulatory standards and maintaining a competitive edge. Robotic compounding technology streamlines the detailed preparation and blending of pharmaceutical compounds using high-tech robotic systems, thereby improving accuracy, efficiency, and safety in drug preparation. Omnicell Inc., a leading healthcare technology firm based in the U.S., for instance, launched a novel automated compounding device called the IVX Station in March 2022. This groundbreaking solution is designed to extend the reach of IV robotic technology throughout the larger market, greatly improving patient safety, precision, cost-effectiveness, supply chain efficiency, and compliance with regulations. The IVX Station is three times quicker than existing IV robotic systems and comes with a highly dependable design that significantly reduces downtime. In addition, it has a small footprint that is well-suited for pharmacy operations.

What Are the Different Segmentations in the Automated Compounding Devices Market?
The automated compounding devices market covered in this report is segmented -

1) By Component: Automated Compounding Systems Equipment, Automated Compounding Systems Software
2) By Product Type: Intravenous Compounding Systems, Oral Compounding Systems, Total Parenteral Nutrition (TPN) Compounding Systems
3) By Mode Of Operation: Fully Automated Compounding Systems, Semi-Automated Compounding Systems
4) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:
1) By Automated Compounding Systems Equipment: Compounding Workstations, Compounding Pumps, Mixing Chambers, Scales And Balances, Dispensing Units, Vial And Syringe Filling Systems, Other Related Equipment (Filtration Devices)
2) By Automated Compounding Systems Software: Prescription Management Software, Workflow Management Software, Monitoring And Control Software, Data Analytics And Reporting Software, Safety And Compliance Software, Integration Software For Hospital Or Pharmacy Management Systems

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/automated-compounding-devices-global-market-report

Which Region Is at the Forefront of the Automated Compounding Devices Market?
North America was the largest region in the automated compounding devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated compounding devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Automated Compounding Devices Global Market Report?

- Market Size Analysis: Analyze the Automated Compounding Devices Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Automated Compounding Devices Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Automated Compounding Devices Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Automated Compounding Devices Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18231

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.